In Vitro to In Vivo Extrapolation (IVIVE) for human health risk assessment

被引：0
|
作者：
Conolly, R.
McMullin, T. [1 ]
Hines, R. N.
Sheets, L. P. [2 ]
Cohen, S. M. [3 ]
机构：
[1] Dow Corning Corp, Midland, MI USA
[2] Bayer CropSci, Res Triangle Pk, NC USA
[3] Univ Nebraska Med Ctr, Omaha, NE USA
来源：
TOXICOLOGY LETTERS | 2013年 / 221卷
关键词：
D O I：
10.1016/j.toxlet.2013.06.051
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [11] In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds
    Fabian, Eric
    Gomes, Caroline
    Birk, Barbara
    Williford, Tabitha
    Hernandez, Tzutzuy Ramirez
    Haase, Christian
    Zbranek, Rene
    van Ravenzwaay, Bennard
    Landsiedel, Robert
    ARCHIVES OF TOXICOLOGY, 2019, 93 (02) : 401 - 416
  • [12] PBTK modeling of selected potential endocrine modulators: In vitro-in vivo extrapolation (IVIVE) and in silico/in vitro based risk assessments
    Haase, C.
    Fabian, E.
    Ramirez, T.
    van Ravenzwaay, B.
    Landsiedel, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S47 - S47
  • [13] PBTK modeling of potential endocrine modulators: In vitro-in vivo extrapolation (IVIVE) and in silico-in vitro based risk assessments
    Fabian, E.
    Haase, C.
    Ramirez, T.
    Gomes, C.
    Birk, B.
    van Ravenzwaay, B.
    Landsiedel, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S79 - S79
  • [14] In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds
    Eric Fabian
    Caroline Gomes
    Barbara Birk
    Tabitha Williford
    Tzutzuy Ramirez Hernandez
    Christian Haase
    Rene Zbranek
    Bennard van Ravenzwaay
    Robert Landsiedel
    Archives of Toxicology, 2019, 93 : 401 - 416
  • [15] Developing an In Vitro to In Vivo Extrapolation (IVIVE) Model to Predict Human Milk-to-Plasma Drug Concentration Ratios
    Yang, Hong
    Xue, Ivy
    Gu, Qimei
    Zou, Peng
    Zhang, Tao
    Lu, Yanhui
    Fisher, Jeffery
    Tran, Doanh
    MOLECULAR PHARMACEUTICS, 2022, : 2506 - 2517
  • [16] In vitro models and opensource toxicokinetic databases to support quantitative in vitro to in vivo extrapolation for human risk assessment
    Clewell, H.
    TOXICOLOGY LETTERS, 2018, 295 : S28 - S28
  • [17] Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment
    Abdulkarim Najjar
    Ans Punt
    John Wambaugh
    Alicia Paini
    Corie Ellison
    Styliani Fragki
    Enrica Bianchi
    Fagen Zhang
    Joost Westerhout
    Dennis Mueller
    Hequn Li
    Quan Shi
    Timothy W. Gant
    Phil Botham
    Rémi Bars
    Aldert Piersma
    Ben van Ravenzwaay
    Nynke I. Kramer
    Archives of Toxicology, 2022, 96 : 3407 - 3419
  • [18] Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment
    Najjar, Abdulkarim
    Punt, Ans
    Wambaugh, John
    Paini, Alicia
    Ellison, Corie
    Fragki, Styliani
    Bianchi, Enrica
    Zhang, Fagen
    Westerhout, Joost
    Mueller, Dennis
    Li, Hequn
    Shi, Quan
    Gant, Timothy W.
    Botham, Phil
    Bars, Remi
    Piersma, Aldert
    van Ravenzwaay, Ben
    Kramer, Nynke I.
    ARCHIVES OF TOXICOLOGY, 2022, 96 (12) : 3407 - 3419
  • [19] Novel In Vitro-In Vivo Extrapolation (IVIVE) Method to Predict Hepatic Organ Clearance in Rat
    Ken-ichi Umehara
    Gian Camenisch
    Pharmaceutical Research, 2012, 29 : 603 - 617
  • [20] Novel In Vitro-In Vivo Extrapolation (IVIVE) Method to Predict Hepatic Organ Clearance in Rat
    Umehara, Ken-ichi
    Camenisch, Gian
    PHARMACEUTICAL RESEARCH, 2012, 29 (02) : 603 - 617
12345